USE OF ARTIFICIAL INTELLIGENCE IN A PULMONARY FIBROSIS CLINIC

Not Applicable

Not yet recruiting

• Conditions: Interstitial Disease

• Registration Number: NCT06852794
• Lead Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Brief Summary

The present study aims to evaluate the usefulness of artificial intelligence (AI) in the back-office of an ILD (Interstitial Lung Disease) clinic.

Detailed Description

Not available

Study Timeline

• Status Verified: 2025-01
• Study First Submitted: 2025-01-30
• Study First Submitted QC: 2025-02-24
• Last Update Submitted: 2025-02-24
• Study First Posted: 2025-02-28
• Last Update Posted: 2025-02-28
• Study Start: 2025-05-01
• Primary Completion: 2025-09-01
• Study Completion: 2026-02-01

Recruitment & Eligibility

• Status: NOT_YET_RECRUITING
• Sex: All
• Target Recruitment: 100

Inclusion Criteria

• Patients attending ILD clinic of the IRCCS Fondazione Policlinico A. Gemelli.

Exclusion Criteria

• Patients unable or unwilling to sign the informed consent
• Patients who are senders of one of the emails chosen for the questionnaire
• Patients with manifest inability to fill out the questionnaire

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Primary Outcome Measures

Name	Time	Method
Variation of VAS scores of clarity of the message in questionnaires administered at T1 and at T2	15 days
Variation of VAS scores of empathy conveyed in questionnaires administered at T1 and at T2	15 days

Secondary Outcome Measures

Name	Time	Method
Percentage of answers recognised correctly as answers provided by AI among the total of answers flagged as provided by AI by study subjects	1 day
Stratify the results by patients' demographic characteristics and past experiences with artificial intelligence systems.	1 day